We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Groupe Crit | EU:CEN | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.60 | -0.82% | 72.60 | 72.20 | 73.40 | 73.40 | 72.60 | 73.00 | 1,053 | 16:40:00 |
RNS Number:6054T CeNeS Pharmaceuticals PLC 23 December 2003 CeNeS Pharmaceuticals plc ("the Company") Directors' Shareholding The Company today announces that the Remuneration Committee has approved to extend the exercise period for options over 99,660 ordinary shares of #1 each in the Company's subsidiary CeNeS Limited (the "Options") held by Alan Goodman, Chairman of the Company and his wife, Eileen Goodman. On exercise the shares issued in CeNeS Limited will be exchanged into 2,023,864 ordinary shares of 1p in the Company. These Options with an exercise price of #1 per share, were granted on 14 January 1997 and were due to expire on 14 January 2004. Following the approval by the Remuneration Committee, the exercise period of these Options has been extended to 22 December 2008. The total number of Ordinary Shares over which options are held by Mr Alan Goodman and his spouse following this notification (including the above Options) remains unchanged at 4,378,287. 23 December 2003 This information is provided by RNS The company news service from the London Stock Exchange END RDSUOAUROORUUAA
1 Year Groupe Crit Chart |
1 Month Groupe Crit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions